Catalent Current Ratio 2012-2018 | CTLT

Current and historical current ratio for Catalent (CTLT) from 2012 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Catalent current ratio for the three months ending December 31, 2018 was 2.08.
Catalent Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $1.07B $0.51B 2.08
2018-09-30 $1.08B $0.53B 2.05
2018-06-30 $1.24B $0.58B 2.15
2018-03-31 $1.21B $0.56B 2.18
2017-12-31 $1.08B $0.48B 2.22
2017-09-30 $1.33B $0.46B 2.91
2017-06-30 $1.06B $0.47B 2.26
2017-03-31 $0.93B $0.39B 2.38
2016-12-31 $0.88B $0.34B 2.64
2016-09-30 $0.77B $0.45B 1.71
2016-06-30 $0.79B $0.39B 2.02
2016-03-31 $0.73B $0.37B 1.96
2015-12-31 $0.68B $0.34B 2.00
2015-09-30 $0.69B $0.35B 1.96
2015-06-30 $0.74B $0.40B 1.85
2015-03-31 $0.65B $0.37B 1.79
2014-12-31 $0.64B $0.35B 1.84
2014-09-30 $0.62B $0.38B 1.64
2014-06-30 $0.69B $0.45B 1.52
2014-03-31 $0.63B $0.41B 1.52
2013-12-31 $0.68B $0.41B 1.65
2013-09-30 $0.00B $0.00B 0.00
2013-06-30 $0.68B $0.41B 1.66
2013-03-31 $0.00B $0.00B 0.00
2012-06-30 $0.71B $0.44B 1.60
2011-06-30 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.414B $2.463B
Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment address the full diversity of the pharmaceutical industry including small molecules, large molecule biologics and consumer health products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. Catalent, Inc. is headquartered in Somerset, New Jersey.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $47.980B 31.89
Takeda Pharmaceutical (TAK) Japan $28.529B 10.56
Grifols (GRFS) Spain $12.699B 15.52
Ionis Pharmaceuticals (IONS) United States $10.053B 31.18
Sage Therapeutics (SAGE) United States $7.794B 0.00
Neurocrine Biosciences (NBIX) United States $7.309B 471.06
Jazz Pharmaceuticals (JAZZ) Ireland $7.187B 10.29
Nektar Therapeutics (NKTR) United States $5.397B 8.61
Tilray (TLRY) United States $5.016B 0.00
United Therapeutics (UTHR) United States $4.322B 7.35
Taro Pharmaceutical Industries (TARO) Israel $4.140B 13.33
FibroGen (FGEN) United States $4.007B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.832B 0.00
Portola Pharmaceuticals (PTLA) United States $2.302B 0.00
PTC Therapeutics (PTCT) United States $2.111B 0.00
USANA Health Sciences (USNA) United States $1.908B 16.01
Xencor (XNCR) United States $1.800B 0.00
Heron Therapeutics (HRTX) United States $1.798B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.769B 0.00
Aerie Pharmaceuticals (AERI) United States $1.759B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.746B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.625B 20.24
Madrigal Pharmaceuticals (MDGL) United States $1.615B 0.00
Endo (ENDP) Ireland $1.604B 2.47
Pacira Pharmaceuticals (PCRX) United States $1.598B 138.39
Zogenix (ZGNX) United States $1.578B 0.00
Corcept Therapeutics (CORT) United States $1.408B 20.45
Tricida (TCDA) United States $1.336B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.288B 0.00
Esperion Therapeutics (ESPR) United States $1.123B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.052B 0.00
TherapeuticsMD (TXMD) United States $1.023B 0.00
Radius Health (RDUS) United States $0.973B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.899B 0.00
CannTrust Holdings (CTST) Canada $0.776B 0.00
Akebia Therapeutics (AKBA) United States $0.767B 0.00
ChemoCentryx (CCXI) United States $0.715B 0.00
ArQule (ARQL) United States $0.698B 0.00
Dermira (DERM) United States $0.598B 0.00
Odonate Therapeutics (ODT) United States $0.586B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.582B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.576B 0.00
Forty Seven (FTSV) United States $0.563B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.554B 0.00
GlycoMimetics (GLYC) United States $0.538B 0.00
TCR2 THERAPTCS (TCRR) United States $0.502B 0.00
Collegium Pharmaceutical (COLL) United States $0.472B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.459B 23.68
KalVista Pharmaceuticals (KALV) United States $0.455B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.448B 0.00
Translate Bio (TBIO) United States $0.447B 0.00
Siga Technologies (SIGA) United States $0.423B 0.00
OptiNose (OPTN) United States $0.411B 0.00
Flexion Therapeutics (FLXN) United States $0.389B 0.00
Aptorum Group (APM) China $0.388B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.376B 0.00
ImmunoGen (IMGN) United States $0.347B 0.00
Mast Therapeutics (SVRA) United States $0.346B 0.00
CASI Pharmaceuticals (CASI) United States $0.317B 0.00
Karyopharm Therapeutics (KPTI) United States $0.295B 0.00
Lannett Co Inc (LCI) United States $0.284B 2.63
Minerva Neurosciences (NERV) United States $0.282B 0.00
Harpoon Therapy (HARP) United States $0.276B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.268B 9.93
AcelRx Pharmaceuticals (ACRX) United States $0.268B 0.00
Xeris Pharmaceuticals (XERS) United States $0.252B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.247B 0.00
Aclaris Therapeutics (ACRS) United States $0.243B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.238B 0.00
Dova Pharmaceuticals (DOVA) United States $0.236B 0.00
Calithera Biosciences (CALA) United States $0.236B 0.00
Molecular Templates (MTEM) United States $0.226B 0.00
Concert Pharmaceuticals (CNCE) United States $0.223B 0.00
Rafael Holdings (RFL) United States $0.216B 0.00
MEI Pharma (MEIP) United States $0.213B 0.00
Ardelyx (ARDX) United States $0.212B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.211B 0.00
Opexa Therapeutics (ACER) United States $0.207B 0.00
Affimed (AFMD) Germany $0.206B 0.00
Aldeyra Therapeutics (ALDX) United States $0.202B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.194B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.191B 0.00
Galectin Therapeutics (GALT) United States $0.189B 0.00
Nature's Sunshine Products (NATR) United States $0.184B 191.20
Recro Pharma (REPH) United States $0.181B 0.00
Jounce Therapeutics (JNCE) United States $0.180B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.178B 0.00
Neon Therapeutics (NTGN) United States $0.176B 0.00
Majesco Entertainment (PTE) United States $0.175B 0.00
IMV INC (IMV) Canada $0.175B 0.00
ElectroCore (ECOR) United States $0.175B 0.00
Redhill Biopharma (RDHL) Israel $0.173B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.170B 0.00
AgeX Therapeutics (AGE) United States $0.167B 0.00
Aratana Therapeutics (PETX) United States $0.165B 0.00
Ocular Therapeutix (OCUL) United States $0.157B 0.00
Tyme Technologies (TYME) United States $0.157B 0.00
Aquestive Therapeutics (AQST) United States $0.156B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.147B 0.00
MediWound (MDWD) Israel $0.133B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.133B 0.00
China SXT Pharmaceuticals (SXTC) China $0.119B 0.00
Iterum Therapeutics (ITRM) Ireland $0.114B 0.00
ProNAi Therapeutics (SRRA) Canada $0.108B 0.00
Cardiome Pharma (CORV) Canada $0.106B 0.00
Neos Therapeutics (NEOS) United States $0.100B 0.00
Nivalis Therapeutics (ALPN) United States $0.100B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.099B 0.00
Natural Alternatives (NAII) United States $0.096B 9.37
Champions Oncology (CSBR) United States $0.095B 0.00
Zafgen (ZFGN) United States $0.094B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.092B 0.00
DURECT (DRRX) United States $0.092B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.091B 0.00
Adherex Technologies (FENC) United States $0.089B 0.00
Bio Blast Pharma (ENLV) Israel $0.088B 0.00
Infinity Pharmaceuticals (INFI) United States $0.086B 0.00
SCYNEXIS (SCYX) United States $0.085B 0.00
Otonomy (OTIC) United States $0.081B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.079B 0.00
Genocea Biosciences (GNCA) United States $0.077B 0.00
Avenue Therapeutics (ATXI) United States $0.075B 0.00
India Globalization Capital (IGC) United States $0.066B 0.00
Capnia (SLNO) United States $0.064B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.063B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.058B 0.00
Forward Pharma (FWP) Denmark $0.056B 0.00
CTI BioPharma (CTIC) United States $0.055B 0.00
Melinta Therapeutics (MLNT) United States $0.048B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.048B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.048B 0.00
Bio-Path Holdings (BPTH) United States $0.045B 0.00
Lipocine (LPCN) United States $0.045B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.044B 0.00
KemPharm (KMPH) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.040B 0.00
ContraFect (CFRX) United States $0.040B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.039B 0.00
Heat Biologics (HTBX) United States $0.038B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
HANCOCK JAFFE (HJLI) United States $0.032B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.028B 0.00
Shineco (TYHT) China $0.028B 4.69
IsoRay (ISR) United States $0.026B 0.00
Achieve Life Sciences (ACHV) United States $0.026B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.026B 3.36
PharmAthene (ALT) United States $0.025B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.023B 0.00
Biomerica (BMRA) United States $0.023B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.020B 0.00
NOVAN INC (NOVN) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
Pain Therapeutics (SAVA) United States $0.019B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Xenetic Biosciences (XBIO) United States $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 4.07
Regulus Therapeutics (RGLS) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Can-Fite Biopharma (CANF) Israel $0.010B 0.00
Achaogen (AKAO) United States $0.010B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.009B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00